## Abstract Differential induction of Epstein‐Barr virus (EBV)‐related antigens was observed after Sendai virusmediated fusion of producer and non‐producer cells with various human and mouse cells. The EBV‐determined early nuclear antigen (ENA), early antigen (EA) and viral capsid antigen (VCA) cou
Induction of Epstein-Barr virus in B-lymphoblastoid cells by human immunodeficiency virus type 1
✍ Scribed by Patrick K. Lai; Xu Li; David J. Volsky
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- French
- Weight
- 861 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Individuals infected with the human immunodeficiency virus (HIV), the etiologic agent of acquired immunodeficiency syndrome (AIDS), often show symptoms associated with reactivation of Epstein-Barr virus (EBV). In this study, we show that exposure of EBV-positive B lymphocytes to HIV-I in vitro induced the EBV replicative cycle in these cells, as evidenced by an increased proportion of cells expressing EBV early antigens (EA) and capsid antigens (VCA). Reactivation of EBV by HIV-I appeared to be virus-dose-dependent and required virus penetration and expression in B cells. Although HIV-I RNA was detected by in situ hybridization in the majority of HIV-I-infected B lymphocytes, induction of EA and VCA was transient and limited to less than 20% of the cell population. The tumor-promoting phorbol ester 12-0-tetradecanoyl-phorbol-13-acetate (TPA) and HIV-I acted synergistically and had similar kinetics in inducing the expression of EBV. Direct reactivation of EBV by HIV-I may contribute to the role of EBV as a factor in the genesis of AIDSrelated conditions.
📜 SIMILAR VOLUMES
## Analysis of antigen uptake and presentation by Epstein-Barr virus-transformed human lymphoblastoid B cells* Epstein-Barr virus-transformed human B cells (EBV-B cells), but not resting B cells or B cells activated by T cell-derived factors, have been shown to support the proliferation of tetanus
## Abstract The tumor promoter TPA (12‐0‐tetradecanoyl‐phorbol‐13‐acetate) efficiently induces the synthesis of Epstein‐Barr virus (EBV) antigens in EBV‐genome‐harboring human lymphoblastoid cells. We attempted to obtain information on the binding of TPA to cells and on the relationship between TPA
## Abstract Four Epstein‐Barr virus‐positive lymphoblastoid cell lines (LCL) were successfully infected __in vitro__ with immunodeficiency virus type 1 (HIV‐1) as demonstrated by reverse transcriptase activity and p24 HIV antigen in culture supernatants, positive cell staining for gag‐encoded HIV p
## Abstract Transformation of human leukocytes by the QIMR‐ WIL strain of EB virus in vitro involves co‐operation between adherent cells (probably macrophages) and non‐adherent cells (predominantly lymphocytes). It was shown that the proliferating cells were derived from the non‐adherent population